[The significance of hypolipemic drugs in the inhibition of progression of renal failure].
Chrzanowski
Witold
W
Klinika Nefrologiczna IMW AM w Łodzi.
D018450:Disease Progression; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D007678:Kidney Glomerulus / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism
D000960:Hypolipidemic Agents; D008074:Lipoproteins